Combination of Sotyktu and Enstilar for Plaque Psoriasis
NCT06329258 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2024-03-25
Summary
combination deucravacitinib and enstilar foam
Conditions
Interventions
- DRUG
-
Enstilar
Add on Enstilar
- DRUG
-
6mg QD
Sponsors & Collaborators
-
Psoriasis Treatment Center of Central New Jersey
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-12-06
- Primary Completion
- 2023-11-13
- Completion
- 2023-11-13
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
The Difference of Microparticles in Patients With Psoriasis Vulgaris Who Received Stelara(Ustekinumab)
NCT02693470 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type Psoriasis
NCT02074982 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments
NCT00967538 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
NCT03073200 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Comparing Zasocitinib (TAK-279) With Deucravacitinib in Adults With Plaque Psoriasis
NCT06973291 ·Status: COMPLETED ·Phase: PHASE3
-
Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis
NCT03827876 ·Status: RECRUITING ·Phase: PHASE4
-
A Study of LY3361237 in Participants With Psoriasis
NCT04975295 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Effectiveness and Safety of Deucravacitinib in Participants With Non-Pustular Palmoplantar and Genital Psoriasis
NCT06042920 ·Status: TERMINATED ·Phase: PHASE4
-
A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis
NCT00267969 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis
NCT02826603 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
NCT06176508 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis
NCT01412944 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis
NCT02931838 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Subcutaneous Secukinumab in Treatment of Subjects With Moderate to Severe Chronic Plaque-type Psoriasis as Compared to Etanercept and Placebo.
NCT01900782 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety/Tolerability of Subcutaneous MK-3222 in Participants With Moderate-to-Severe Chronic Plaque Psoriasis (MK-3222-012)
NCT01936688 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate Raptiva in Adults With Moderate to Severe Plaque Psoriasis Who Are Candidates for Systemic Therapy
NCT00109317 ·Status: COMPLETED ·Phase: PHASE3
-
Secukinumab Study in PSOriasis Exploring pruRITUS Intensity and Lesional Biomarkers
NCT02362789 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of an Injectable Biologic and U0279 as Combination Therapy for Severe Plaque-Type Psoriasis
NCT00832364 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study of the Clinical Activity, Safety, and Tolerability of SRT2104 in Subjects With Moderate to Severe Plaque-Type Psoriasis
NCT01154101 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate Raptiva in Combination With Topical Psoriasis Therapies
NCT00096980 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Study in Participants With Moderate to Severe Psoriasis
NCT01474512 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)
NCT02346240 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Safety and Efficacy of Infliximab in Patients With Psoriasis
NCT00106834 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Compare U0267 Against Vehicle in Subjects With Plaque-type Psoriasis One of Two Phase 3 Studies
NCT00688519 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3972406 in Adult Participants With Moderate-to-Severe Plaque Psoriasis
NCT06176768 ·Status: COMPLETED ·Phase: PHASE2